Toggle Site Contrast

2022 Medicine Disclosure Logs

Anti-VEGF Treatment January 2022 - April 2022 - FOI 1383,

Blood Gas Analysers - FOI 1709,

Breathing Circuit Supplier - FOI 1696,

Cardiac Devices Electronic Database - FOI 1680,

Collection of performance data for the CCG2 CQUIN scheme “Appropriate antibiotic prescribing for UTI in adults aged 16+” between 1st April 2022 and the 1st April 2023 - FOI 1356,

Critical Care Beds Information - FOI 1372,

Do not resuscitate policy June 2022 - FOI 1502,

Do not resuscitate policy attachment 1 - FOI 1502,

Drugs used for patient treatments - FOI 1062,

Drugs used for Dermatology and Gastro patients March to May 2022 - FOI 1366,

Drugs used to treat Melanoma, Renal carcinoma & Oesophageal cancer - FOI 1297,

Prescribed cannabis-based medicinal products - FOI 1723,

Medical / EBMA Devices - FOI 1702,

Shigellosis – FOI 1089,

Ventilated Beds Dec 2021 FOI 1078,

Patients registered for Haemophilia treatment- FOI 1301,

Treatment of patients with Chronic Lymphocytic Leukaemia March to April 2022 - FOI 1341,

Number of patients who died whilst awaiting discharge - FOI 1379,

Drug treatments for Melanoma, Renal Cell Carcinoma and GI Cancer May to July 2022 - FOI 1539,

Drug Treatments used April to June 2022 - FOI 1492,

Dabrafenib + Trametinib for cancer treatments Jan to June 2022 - FOI 1468,

Usages of medicines in secondary care Oct 2021 to March 2022 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 1 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 2 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 3 - FOI 1353,

Usages of medicines in secondary care Oct 2021 to March 2022 Attachment 4 - FOI 1353,

Portable Bilirubin Meter Information - FOI 1497,

Treatment of Patients with Melanoma - FOI 1279,

Drugs used in Treatments Dec 2021 to May 2022 - FOI 1364,

Usage of Intra-Vitreal Injections Jan to April 2022 - FOI 1365,

Medication used in total knee replacements - FOI 1624,

Remote Monitoring of Pharmacy fridges - FOI 1852,

Patients diagnosed with HR+ adjuvant breast cancer treated with trastuzumab monotherapy Nov 21 to Nov 22 - FOI 1826,

Contacting patients for appointments and surgery

We have begun sending text messages and letters out to patients on our waiting lists.

Please be reassured that these messages are legitimate. It is important that you respond to these messages as quickly as possible after receiving them. If you need to get in contact with us, please use either the email address or telephone number provided on your original letter.

You may receive a message:

To ask if you still require treatment and would like to remain on our waiting list.

or,

You have been waiting over 40 weeks for an appointment or procedure and would like to request to move to another hospital, who may be able to see you sooner.